Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Magid A Fahim

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
AIMS Genetics|August 23, 2019
Cardiac biomarkers in dialysisUsman Mahmood, David W Johnson, Magid A Fahim
Trials|January 19, 2022
Statistical analysis plan for Better Evidence for Selecting Transplant Fluids (BEST-Fluids): a randomised controlled trial of the effect of intravenous fluid therapy with balanced crystalloid versus saline on the incidence of delayed graft function in deceased donor kidney transplantationElaine M Pascoe, Steven J Chadban, Magid A Fahim, et al.
The Cochrane Database of Systematic Reviews|December 14, 2011
Cardiac testing for coronary artery disease in potential kidney transplant recipientsLouis W Wang, Magid A Fahim, Andrew Hayen, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 25, 2011
Cardiac testing for coronary artery disease in potential kidney transplant recipients: a systematic review of test accuracy studiesLouis W Wang, Magid A Fahim, Andrew Hayen, et al.
Clinical Journal of the American Society of Nephrology : CJASN|February 26, 2015
N-terminal pro-B-type natriuretic peptide variability in stable dialysis patientsMagid A Fahim, Andrew Hayen, Andrea R Horvath, et al.
Clinical Chemistry and Laboratory Medicine|December 21, 2014
Biological variation of high sensitivity cardiac troponin-T in stable dialysis patients: implications for clinical practiceMagid A Fahim, Andrew D Hayen, Andrea R Horvath, et al.
Trials|April 15, 2021
Conducting clinical trials during the COVID-19 pandemic-a collaborative trial network responseLaura Robison, Yeoungjee Cho, Andrea K Viecelli, et al.
Trials|May 27, 2020
Study Protocol for Better Evidence for Selecting Transplant Fluids (BEST-Fluids): a pragmatic, registry-based, multi-center, double-blind, randomized controlled trial evaluating the effect of intravenous fluid therapy with Plasma-Lyte 148 versus 0.9% saline on delayed graft function in deceased donor kidney transplantationMichael G Collins, Magid A Fahim, Elaine M Pascoe, et al.
Kidney & Blood Pressure Research|December 4, 2017
Carvedilol and Cardiac Biomarkers in Dialysis Patients: Secondary Analysis of a Randomized Controlled TrialMatthew A Roberts, Darsy Darssan, Sunil V Badve, et al.
Lancet (London, England)|June 21, 2023
Balanced crystalloid solution versus saline in deceased donor kidney transplantation (BEST-Fluids): a pragmatic, double-blind, randomised, controlled trialMichael G Collins, Magid A Fahim, Elaine M Pascoe, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
AIMS Genetics|August 23, 2019
Cardiac biomarkers in dialysisUsman Mahmood, David W Johnson, Magid A Fahim
Trials|January 19, 2022
Statistical analysis plan for Better Evidence for Selecting Transplant Fluids (BEST-Fluids): a randomised controlled trial of the effect of intravenous fluid therapy with balanced crystalloid versus saline on the incidence of delayed graft function in deceased donor kidney transplantationElaine M Pascoe, Steven J Chadban, Magid A Fahim, et al.
The Cochrane Database of Systematic Reviews|December 14, 2011
Cardiac testing for coronary artery disease in potential kidney transplant recipientsLouis W Wang, Magid A Fahim, Andrew Hayen, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 25, 2011
Cardiac testing for coronary artery disease in potential kidney transplant recipients: a systematic review of test accuracy studiesLouis W Wang, Magid A Fahim, Andrew Hayen, et al.
Clinical Journal of the American Society of Nephrology : CJASN|February 26, 2015
N-terminal pro-B-type natriuretic peptide variability in stable dialysis patientsMagid A Fahim, Andrew Hayen, Andrea R Horvath, et al.
Clinical Chemistry and Laboratory Medicine|December 21, 2014
Biological variation of high sensitivity cardiac troponin-T in stable dialysis patients: implications for clinical practiceMagid A Fahim, Andrew D Hayen, Andrea R Horvath, et al.
Trials|April 15, 2021
Conducting clinical trials during the COVID-19 pandemic-a collaborative trial network responseLaura Robison, Yeoungjee Cho, Andrea K Viecelli, et al.
Trials|May 27, 2020
Study Protocol for Better Evidence for Selecting Transplant Fluids (BEST-Fluids): a pragmatic, registry-based, multi-center, double-blind, randomized controlled trial evaluating the effect of intravenous fluid therapy with Plasma-Lyte 148 versus 0.9% saline on delayed graft function in deceased donor kidney transplantationMichael G Collins, Magid A Fahim, Elaine M Pascoe, et al.
Kidney & Blood Pressure Research|December 4, 2017
Carvedilol and Cardiac Biomarkers in Dialysis Patients: Secondary Analysis of a Randomized Controlled TrialMatthew A Roberts, Darsy Darssan, Sunil V Badve, et al.
Lancet (London, England)|June 21, 2023
Balanced crystalloid solution versus saline in deceased donor kidney transplantation (BEST-Fluids): a pragmatic, double-blind, randomised, controlled trialMichael G Collins, Magid A Fahim, Elaine M Pascoe, et al.
Pageof 2